Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 574

1.

Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.

Kirchhof P, Breithardt G, Camm AJ, Crijns HJ, Kuck KH, Vardas P, Wegscheider K.

Am Heart J. 2013 Sep;166(3):442-8. doi: 10.1016/j.ahj.2013.05.015. Epub 2013 Jul 30.

2.

Rationale and current perspective for early rhythm control therapy in atrial fibrillation.

Van Gelder IC, Haegeli LM, Brandes A, Heidbuchel H, Aliot E, Kautzner J, Szumowski L, Mont L, Morgan J, Willems S, Themistoclakis S, Gulizia M, Elvan A, Smit MD, Kirchhof P.

Europace. 2011 Nov;13(11):1517-25. doi: 10.1093/europace/eur192. Epub 2011 Jul 22. Review.

3.

The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.

Hagens VE, Van Gelder IC, Crijns HJ; RAte Control Versus Electrical Cardioversion Of Persistent Atrial Fibrillation (RACE) Study Group.

Card Electrophysiol Rev. 2003 Jun;7(2):118-21. Review.

PMID:
14618033
4.

Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.

Derejko P, Polańska M, Chojnowska L, Michałowska I, Wójcik A, Piotrowicz E, Lech A, Kłopotowski M, Baranowski R, Przybylski A, Bilińska M, Sierpiński R, Walczak F, Szumowski L.

Kardiol Pol. 2013;71(1):17-24.

5.

Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation).

Camm AJ, Breithardt G, Crijns H, Dorian P, Kowey P, Le Heuzey JY, Merioua I, Pedrazzini L, Prystowsky EN, Schwartz PJ, Torp-Pedersen C, Weintraub W.

J Am Coll Cardiol. 2011 Jul 26;58(5):493-501. doi: 10.1016/j.jacc.2011.03.034.

6.

Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.

Liu J, Sylwestrzak G, Barron J, Rosenberg A, White J, Whitney J, Redberg R, Malenka D.

Curr Med Res Opin. 2014 Sep;30(9):1707-13. doi: 10.1185/03007995.2014.922061. Epub 2014 Jun 2.

PMID:
24809834
7.

Risks and benefits of rate control versus maintenance of sinus rhythm.

Saxonhouse SJ, Curtis AB.

Am J Cardiol. 2003 Mar 20;91(6A):27D-32D. Review.

PMID:
12670639
8.

Treatment of atrial fibrillation.

Bajpai A, Savelieva I, Camm AJ.

Br Med Bull. 2008;88(1):75-94. doi: 10.1093/bmb/ldn046. Epub 2008 Dec 5. Review.

PMID:
19059992
10.

Atrial fibrillation: the rate versus rhythm management controversy.

Camm AJ, Savelieva I.

J R Coll Physicians Edinb. 2012;42 Suppl 18:23-34. doi: 10.4997/JRCPE.2012.S03.

PMID:
22518391
11.

Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'.

Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, Cosio F, Crijns H, Diener HC, Goette A, Israel CW, Kuck KH, Lip GY, Nattel S, Page RL, Ravens U, Schotten U, Steinbeck G, Vardas P, Waldo A, Wegscheider K, Willems S, Breithardt G.

Eur Heart J. 2009 Dec;30(24):2969-77c. doi: 10.1093/eurheartj/ehp235. Epub .

12.

Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.

Morillo CA, Verma A, Connolly SJ, Kuck KH, Nair GM, Champagne J, Sterns LD, Beresh H, Healey JS, Natale A; RAAFT-2 Investigators.

JAMA. 2014 Feb 19;311(7):692-700. doi: 10.1001/jama.2014.467. Erratum in: JAMA. 2014 Jun 11;311(22):2337.

PMID:
24549549
14.

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.

Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.

Am J Cardiol. 2003 Mar 20;91(6A):15D-26D. Review.

PMID:
12670638
15.

Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.

Rodgers M, McKenna C, Palmer S, Chambers D, Van Hout S, Golder S, Pepper C, Todd D, Woolacott N.

Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. Review.

16.

Do we need pharmacological therapy for atrial fibrillation in the ablation era?

Lévy S.

J Interv Card Electrophysiol. 2006 Dec;17(3):189-94. Epub 2007 Mar 6. Review.

PMID:
17340189
17.

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study.

Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S, Walter S, Tebbe U; STAF Investigators.

J Am Coll Cardiol. 2003 May 21;41(10):1690-6.

18.

Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study.

Opolski G, Torbicki A, Kosior D, Szulc M, Zawadzka M, Pierścińska M, Kołodziej P, Stopiński M, Wozakowska-Kapłon B, Achremczyk P, Rabczenko D.

Kardiol Pol. 2003 Jul;59(7):1-16; discussion 15-16.

PMID:
14560344
19.

Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry.

Meinertz T, Kirch W, Rosin L, Pittrow D, Willich SN, Kirchhof P; ATRIUM investigators.

Clin Res Cardiol. 2011 Oct;100(10):897-905. doi: 10.1007/s00392-011-0320-5. Epub 2011 May 1.

20.
Items per page

Supplemental Content

Write to the Help Desk